Company releases

Nightingale Health Plc’s financial reporting and Annual General Meeting in financial year 2022 – 2023

Jun 15, 2022
Press releases

Further landmark evidence released to showcase the ability of Nightingale Health’s technology to predict hundreds of diseases from a single blood sample

Jun 14, 2022
Managers' transactions

Nightingale Health Plc – Managers’ transactions – Timo Soininen

Jun 10, 2022
Company releases

Notice to the Extraordinary General Meeting of Nightingale Health Plc

Jun 08, 2022
Press releases

Nightingale Health partners with Physitrack, expanding the availability of its preventative wellbeing service Livit to Germany, the UK and in the Nordics

Jun 08, 2022
Press releases

Analysis: Nightingale Health’s net impact among the top 7 percent of companies worldwide

May 31, 2022
Company releases

Conversion of Nightingale Health Plc’s Series A shares and EMP shares to Series B shares

May 19, 2022
Press releases

Nightingale Health launches consumer service Livit by Nightingale Health utilizing its at-home testing solution

Mar 31, 2022
Company releases

Nightingale’s Board of Directors resolved on new share-based incentive plans

Mar 18, 2022
Company releases

Nightingale Health Group’s Half-year report 1 July 2021 – 31 December 2021: Progressing faster than expected in line with strategy

Feb 24, 2022
Press releases

Nightingale to publish half-year report for July – December 2021 on 24 February 2022

Feb 16, 2022
Company releases

Conversion of Nightingale Health Plc’s Series A shares to Series B shares

Feb 08, 2022
Company releases

Nightingale has completed the acquisition of Finnish genetic testing company Negen

Feb 03, 2022
Press releases

Nightingale’s information security management certification continued with outstanding results in surveillance audit

Jan 20, 2022
Company releases

Nightingale introduces combination of its proprietary blood test and genomics: acquires Finnish genetic testing company Negen and launches international centre of excellence for genomic data analysis

Jan 18, 2022